Biochemical effect of intravenous arginine butyrate in X-linked adrenoleukodystrophy

Journal of Pediatrics

Volumn 142, Issue 6, 2003, Pages 709-713

  McGovern, Margaret M ^a   Wasserstein, Melissa P ^b   Aron, Alan ^b   Perrine, Susan P ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE BUTYRATE; ARGININE DERIVATIVE; LONG CHAIN FATTY ACID; LORENZO OIL; TRIOLEIN; UNCLASSIFIED DRUG;

ADRENOLEUKODYSTROPHY; ARTICLE; BEHAVIOR; BIOCHEMISTRY; BLOOD ANALYSIS; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIET; DISEASE COURSE; DRUG EFFECT; DRUG INFUSION; HEMIZYGOTE; HETEROZYGOTE; HUMAN; IMAGE ANALYSIS; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TIME; X CHROMOSOME LINKAGE;

EID: 0038809137     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.201     Document Type: Article

References (18)

1. Moser HW, Smith KD, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 2325-50.
2. Aubourg P. X-linked adrenoleukodystrophy. In: Moser HW, editor. Handbook of clinical neurology. Amsterdam: Elsevier; 1996. p. 447-83.
3. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-30.
4. Mosser J, Lutz Y, Stoekel ME, Sarde CO, Kretz C, Douar AM, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3:265-71.
5. Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P, et al. Retroviral mediated gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci U S A 1995;92:1674-8.
6. Shinnoh N, Yamada T, Yoshimura T, Furuya H, Yoshida Y, Suzuki Y, et al. Adrenoleukodystrophy: the restoration of peroxisomal beta oxidation by transfection of normal cDNA. Biochem Biophys Res Commun 1995;210:830-6.
7. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, et al. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1997;94:9366-71.
8. McGuinness MC, Zhang HP, Smith KD. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol Genet Metab 2001;74:256-63.
9. Kemp S, Wei HM, Lu JF, Braiterman LT, McGuiness MC, Moser AB, et al. Gene redundancy and pharmacological gene therapy: implications for x-linked adrenoleukodystrophy. Am J Hum Genet 1995;57:292-301.
10. Perrine SP, Ginder GD, Faller DV, Dover GJ, Ikuta H, Witkowska E, et al. A short-term trial of butyrate to stimulate fetal globin gene expression in the β-globin disorders. N Engl J Med 1993;328:81-6.
11. Atweh GF, Sutton, Nasif I, Dover GJ, Wallenstein S, Wright S, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 1999;93:1790-7.
12. Dover GJ, Brusilow S, Charache P. Induction of fetal hemoglobin in subjects with sickle cell disease by oral sodium phenylbutyrate. Blood 1994;84:339-43.
13. Moser AB, Jones DS, Raymond GV, Moser HW. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 1999;24:187-97.
14. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000;356:713-8.
15. Poulos A, Gibson R, Sharp P, Beckman K, Grattan Smith P. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann Neurol 1994;36:741-61.
16. Rasmussen M, Moser AB, Borel J, Khangoora S, Moser HW. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trieruvcate and trioleate oils (Lorenzo's oil). Neurochem Res 1994;19:1073-82.
17. Daniel P, Brazier M, Cerutti I, Pieri F, Tardivel I, Desmet G, et al. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine buwrate salts. Clin Chim Acta 1989;255-64.
18. Barker PB, Artenov D, Raymond GV, Horska A, Moser HW. Detection of 4-phenylbutyrate in the human brain by in vivo proton MR spectroscopy. ISMR 8th Scientific Meeting, Denver, Colorado, 2000.